Patent · US Active

Methods of treating autoimmune diseases caused by small intestinal bacterial overgrowth

US8197805B2 · kind B2 · utility

75Cited by
128References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 28, 2011
Grant dateJun 12, 2012
Priority date
Expiry dateMar 28, 2031

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/065
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed is a method of diagnosing autoimmune diseases, such as multiple sclerosis and systemic lupus erythematosus, which involves detecting the presence of small intestinal bacterial overgrowth (SIBO) in a human subject having at least one symptom associated with a suspected diagnosis an autoimmune disease. Also disclosed is a method of treating these autoimmune diseases, which involves at least partially eradicating a SIBO condition in the human subject. The method includes administration of antimicrobial or probiotic agents, or normalizing intestinal motility by employing a prokinetic agent. Also disclosed is a kit for the diagnosis or treatment of autoimmune diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.